Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth
Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, today announced the […]
Insightful Science Acquires Omiq to Add Cloud-Based Machine Learning to its Flow Cytometry Capabilities
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it […]
Insightful Science Acquires Protein Metrics to Expand its R&D Solution to Include Proteomics
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it […]
Rebeca Sanchez Sarmiento Joins Insightful Science and Dotmatics as Chief Financial Officer
Insightful Science, the world’s most widely adopted software platform for scientific R&D and collaboration, today announced […]
Insightful Science Acquires LabArchives to Expand its Electronic Lab Notebook and LIMS Solutions for Scientific Discovery
Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more